CD40 agonist-induced IL-12p40 potentiates hepatotoxicity

Fetal origin confers radio-resistance on liver macrophages via p21cip1/WAF1

(2019) Radika Soysa et al.   JOURNAL OF HEPATOLOGY

Stellate Cells, Hepatocytes, and Endothelial Cells Imprint the Kupffer Cell Identity on Monocytes Colonizing the Liver Macrophage Niche

(2019) Johnny Bonnardel et al.   IMMUNITY

Concepts for agonistic targeting of CD40 in immuno-oncology

(2019) David M. Richards et al.   Human Vaccines & Immunotherapeutics

A BISPECIFIC MOLECULE TARGETING CD40 AND TUMOR ANTIGEN MESOTHELIN ENHANCES TUMOR-SPECIFIC IMMUNITY

(2019) Shiming Ye et al.   Cancer Immunology Research

The Neutrophil’s Choice: Phagocytose vs Make Neutrophil Extracellular Traps

(2018) Angelo A. Manfredi et al.   Frontiers in Immunology

Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells

(2017) Amir A. Al-Khami et al.   OncoImmunology

Understanding cachexia as a cancer metabolism syndrome

(2016) P E Porporato   Oncogenesis

Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential

(2015) Padmanee Sharma et al.   CELL

Clinical and Biological Effects of an Agonist Anti-CD40 Antibody: A Cancer Research UK Phase I Study

(2015) P. Johnson et al.   CLINICAL CANCER RESEARCH

Systemic Agonistic Anti-CD40 Treatment of Tumor-Bearing Mice Modulates Hepatic Myeloid-Suppressive Cells and Causes Immune-Mediated Liver Damage

(2015) José Medina-Echeverz et al.   Cancer Immunology Research

Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials

(2014) Sufia Butt Hassan et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Agonistic CD40 Antibodies and Cancer Therapy

(2013) R. H. Vonderheide et al.   CLINICAL CANCER RESEARCH

Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy

(2013) Myriam N. Bouchlaka et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Role of Crosslinking for Agonistic CD40 Monoclonal Antibodies as Immune Therapy of Cancer

(2013) L. P. Richman et al.   Cancer Immunology Research

Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice

(2010) Manabu Kinoshita et al.   JOURNAL OF HEPATOLOGY

Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation

(2009) Erica L Carpenter et al.   Journal of Translational Medicine

The role of CD40 and CD154/CD40L in dendritic cells

(2009) Daphne Y. Ma et al.   SEMINARS IN IMMUNOLOGY

Isolation of murine intrahepatic immune cells employing a modified procedure for mechanical disruption and functional characterization of the B, T and natural killer T cells obtained

(2008) K. G. Blom et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY